Deep Brain Stimulation for Parkinson's Disease
Author Information
Author(s): Khan Zubair Mustafsa, Ahmad Shahzeb, Qadri Haseeb Mehmood, Khizar Ahtesham, Bashir Asif
Primary Institution: Punjab Institute of Neurosciences, Lahore, Pakistan
Hypothesis
Bilateral Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) can reduce the need for medication in Parkinson's disease patients.
Conclusion
Bilateral STN DBS is an effective treatment for early-stage Parkinson's disease, significantly reducing the need for levodopa and improving motor symptoms.
Supporting Evidence
- LEDD reduced by 55.03% after DBS.
- UPDRS-III improved by 80.49% post-surgery.
- Time spent with dyskinesia decreased by 17.54%.
- Time spent off medication increased by 22.44%.
Takeaway
Doctors used a special brain surgery to help people with Parkinson's disease take less medicine and feel better.
Methodology
This was a retrospective cohort study involving 49 patients who underwent bilateral STN DBS over five years.
Potential Biases
There may be risks of bias due to the non-probability sampling method.
Limitations
The study's weaknesses include its retrospective nature, limited sample size, and shorter follow-up duration.
Participant Demographics
The mean age of participants was 56.79 years, with 80% male and 20% female.
Statistical Information
P-Value
0.0001
Confidence Interval
95%
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website